Octapharma announced today the results from the ProDERM study on the efficacy and safety of Octagam® 10% [Immune Globulin Intravenous (Human)], in adult dermatomyositis (DM) patients have been published in…
Continue Reading
Octapharma announced today the results from the ProDERM study on the efficacy and safety of Octagam® 10% [Immune Globulin Intravenous (Human)], in adult dermatomyositis (DM) patients have been published in…
Continue Reading
Please visit Myositis Association Australia
Continue Reading
PLEASE ACT! The request that Medicare begin funding power seat elevation and standing systems has been in the works for some time. The Medicare program currently denies coverage for seat…
Continue Reading
One lucky fan is going to win the Ultimate Peter Frampton Fan Experience to include a 30 minute virtual meeting with Peter Frampton himself! Grammy-winning guitarist Peter Frampton is one…
Continue Reading
The Myositis Association is KNEE DEEP in Annual Patient Conference planning! As we are in the process of curating an OUTSTANDING EXPERIENCE for our guests, we want to share some…
Continue Reading